Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;29(5):1071-1073.
doi: 10.1038/s41418-022-00976-3. Epub 2022 Mar 29.

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

Affiliations

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

Kelvin César de Andrade et al. Cell Death Differ. 2022 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests. KCA, CAK, JNH, MNF, CPK, and SAS are unpaid members of the ClinGen TP53 Variant Curation Expert Panel. MNF is co-developer of CancerGene Connect and member of the National Accreditation Program for Breast Centers Board of Directors representing the National Society of Genetic Counselors.

Figures

Fig. 1
Fig. 1. A high-level system architecture of the redesigned NCI-sponsored TP53 database (https://tp53.isb-cgc.org).
Application Environment: Google Cloud platform-Google App Engine Flexible Environment. Application Framework: Flask. Programming Language: Python 3.7. Object Data Storage: Google Cloud Storage. Database Platform: Google BigQuery. For questions and requests: tp53-info@isb-cgc.org. The application source code can be found in GitHub: https://github.com/isb-cgc/TP53.

References

    1. Levine AJ. Spontaneous and inherited TP53 genetic alterations. Oncogene. 2021;40:5975–83. doi: 10.1038/s41388-021-01991-3. - DOI - PMC - PubMed
    1. Guha T, Malkin D. Inherited TP53 mutations and the Li-Fraumeni syndrome. Cold Spring Harb Perspect Med. 2017;7:a026187. doi: 10.1101/cshperspect.a026187. - DOI - PMC - PubMed
    1. de Andrade KC, Khincha PP, Hatton JN, Frone MN, Wegman-Ostrosky T, Mai PL, et al. Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study. Lancet Oncol. 2021;22:1787–98. doi: 10.1016/S1470-2045(21)00580-5. - DOI - PMC - PubMed
    1. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 1994;22:3551–5. - PMC - PubMed
    1. Bouaoun L, Sonkin D, Ardin M, Hollstein M, Byrnes G, Zavadil J, et al. TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum Mutat. 2016;37:865–76. doi: 10.1002/humu.23035. - DOI - PubMed

Publication types

Substances

Associated data